跳到正文
11月4日周三
  1. WHO · Official News OData

    WHO建议ChAdOx1与mRNA-1469加入刚果(金)Tumaini试验,Bundibugyo病毒疫苗首次于疫情期间接受临床评估

    WHO候选疫苗优先技术咨询小组基于现有临床前和早期临床证据,建议将牛津大学与印度血清研究所的ChAdOx1及Moderna的mRNA-1469加入刚果(金)Tumaini试验,系针对Bundibugyo病毒的疫苗首次在疫情期间接受临床评估,待国家批准后入组。

    关注理由:针对Bundibugyo病毒的候选疫苗首次在疫情期间进入临床评估,Tumaini多疫苗试验与治疗研究并行推进,结果时间表明确,可跟踪疫情期间疫苗评价模式的验证进展。

  2. WHO · Official News OData

    感染病学:Progress against neglected tropical diseases requires sustained action

    原文摘录:WHO / Monika Mey Local health workers in Cambodia are trained in surveillance techniques, including stool examination using Kato-Katz, to detect schistosomiasis eggs, identify potential hotspots and support early detection and treatment. … int Related Global report on neglected tropical diseases 2026 Ending the neglect to attain the Sustainable Development Goals: A road map for neglected tropical diseases 2021–2030 WHO's work on neglected tropical diseases More WHO Global Neglected Tropical Diseases Programme

    关注理由:关于感染病学的这条内容有明确出处,主要发现和适用人群可在原文中继续核查。

  3. PubMed · The EMBO Journal

    感染病学:Tetraspanin CD81 restricts Ebola virus infection and is antagonized by glycoprotein GP and matrix protein VP40.

    原文摘录:Viruses manipulate host cell membranes to evade antiviral immunity, prevent superinfection, and optimize their replication and spread. … Our study provides insights into the roles of NF-κB signaling in Ebola virus replication and immunopathogenesis, and identifies tetraspanin CD81 as a potentially druggable Ebola virus-inhibitory host factor

11月3日周二
11月2日周一
  1. PubMed · Clinical Microbiology Reviews

    抗菌素骨水泥间隔物:一项关于假体周围关节感染两期置换的综述(1988–2024年文献)

    《Clinical Microbiology Reviews》发表综述,回顾1988至2024年同行评议文献及作者临床经验,总结抗菌素骨水泥间隔物(ALCS)在慢性假体周围关节感染(PJI)两期置换第一期的应用。文章指出间隔物中抗菌药物剂量缺乏指导,且全身吸收水平不明,机械并发症如关节半脱位及肾毒性、过敏反应仍存在,提出骨科、感染科与药师多学科协作及个体化给药可能改善预后。

10月29日周四
  1. PubMed · AIDS

    常规医疗中来那卡韦(lenacapavir)用于HIV暴露前预防的早期患者报告结局与计划持续用药研究

    一项多中心研究评估了在常规医疗中开始每半年一次来那卡韦(lenacapavir, LEN)HIV暴露前预防(PrEP)者的早期患者报告结局。减少给药频率带来的便利是启用LEN的主要动机,尽管注射部位反应常见但多为轻度,总体满意度较高;持续性结节和疼痛是患者对未来继续用药的主要顾虑。研究提示需以患者为中心的咨询和实施策略来优化长效PrEP的长期坚持。

10月28日周三
10月23日周五
  1. PubMed · European Journal of Pharmacology

    感染病学:Pharmacodynamic evaluation of the novel vancomycin derivative LYSC98.

    原文摘录:LYSC98 is a novel synthetic derivative from chemical modification of vancomycin. In this study, the antibacterial efficacy of LYSC98 was systematically evaluated against multiple clinically significant pathogens using Minimal Inhibitory Concentration (MIC … These results indicate that, within the strains, doses and models tested, LYSC98 is active against the Gram-positive species examined and is more effective than vancomycin in selected infection models

10月22日周四
  1. PubMed · Journal of Medicinal Chemistry

    感染病学:Development of N-Hydroxyindole-2-Carboxamides as New Host-Targeted Broad-Spectrum Antiviral Agents Against Human Respiratory Viruses.

    原文摘录:Endoplasmic reticulum (ER) oxidoreductases are promising targets for host-targeted antiviral agents (HTAs) because of their essential role in protein folding, including the maturation of viral proteins. … This new class of HTAs provides promising leads for drug discovery targeting viral envelope protein maturation vulnerabilities and is suitable for developing new BSAs

10月21日周三
  1. PubMed · Biosensors and Bioelectronics

    沙眼衣原体检测:二抗介导质量放大的信号-on免标记电化学侧流免疫分析(体外方法研究)

    研究者开发了一种针对沙眼衣原体的信号-on、免标记电化学侧流免疫分析(eLFIA),采用间接竞争格式,通过二抗在电极-膜界面形成大分子组装以放大阻抗信号。该方法检出限为10 ng/mL,定量范围约10–500 ng/mL(CV<15%),灵敏度较单抗格式提升约5倍,在模拟尿液、人工唾液和模拟阴道分泌物中回收率约80–120%,并配合NFC便携式读出器验证。

10月20日周二
  1. PubMed · Social Science & Medicine

    巴黎北郊结核病与移民的多点民族志研究:诊断怀疑与治疗依从可以并存

    法国AP-HP六所大学医院、两所市际医院中心及Samusocial流动医疗队开展多点民族志,纳入82例结核病患者的深入半结构式访谈(65男17女,估计在法平均居住约10年)。结果显示,多数患者遵循处方治疗,但部分患者对生物医学诊断持持续怀疑,并将其病因归因于缺乏稳定工作与住房、居留身份不确定及制度性疏离,研究者称之为“语义阻抗”。

10月16日周五
  1. PubMed · Biochimica et Biophysica Acta (BBA) - Biomembranes

    细胞内固体核磁共振研究噬菌体感染杀鲑气单胞菌引起的膜扰动

    一项体外/活菌固体核磁共振研究以氘代棕榈酸标记杀鲑气单胞菌亚种完整菌膜,比较A-layer阳性噬菌体敏感株AS-R3、A-layer阴性敏感株AS-R5与不敏感株BIM93在噬菌体SW69-9暴露后的膜序变化。敏感株膜序明显下降,AS-R5活力显著丧失,BIM93维持膜结构与活力,AS-R3呈膜扰动但裂解有限的中间表型,提示噬菌体诱导的膜扰动取决于噬菌体敏感性与细菌包膜结构。

  2. WHO · Disease Outbreak News OData

    感染病学:Middle East respiratory syndrome coronavirus - Kingdom of Saudi Arabia

    原文摘录:Disease Outbreak News Middle East respiratory syndrome coronavirus - Kingdom of Saudi Arabia 15 October 2026 See all DONs related to this event Situation at a glance Between 1 January and 5 October 2026, the Kingdom of Saudi Arabia reported eight laborato … int/emergencies/disease-outbreak-news/item/2026-DON618 See all DONs related to this event

10月14日周三
10月13日周二
10月10日周六
  1. WHO · Disease Outbreak News OData

    感染病学:Pneumonia of undetermined etiology - the Russian Federation

    原文摘录:Disease Outbreak News Pneumonia of undetermined etiology - Russian Federation 10 October 2026 See all DONs related to this event Situation at a glance On 2 October 2026, WHO became aware through media reports of the death of an employee of the Irkutsk Ant … item/2026-DON620 See all DONs related to this event

    关注理由:这条感染病学资料适合作为深入阅读入口,尤其要关注研究方法与结论是否匹配。

10月7日周三
  1. PubMed · Bioorganic & Medicinal Chemistry Letters

    炔基6-硝基喹喔啉衍生物抗结核活性的构效关系研究

    一系列喹喔啉衍生物经设计并在结核分枝杆菌H37Rv株上评估体外抗结核活性,属体外研究。多个衍生物MIC90低于10 μM,其中化合物4d和3b活性最强,MIC分别为0.97 μM和0.94 μM。构效关系分析显示6-硝基喹喔啉核心和炔键连接子对活性关键,叔醇侧链衍生物活性较好,化合物4h选择性指数较优但水溶性低,为该骨架进一步优化提供方向。

8月29日周六
6月30日周二